Safety
Thymosin Alpha-1
Adverse-event report summary for Thymosin Alpha-1, drawn from the FDA Adverse Event Reporting System (FAERS).
- Total reports
- 36
- Reports flagged serious
- 36
“Serious” is FAERS’s own report-level flag (e.g. death, hospitalization, or another outcome the reporter marked as serious) and does not indicate a verified or compound-caused outcome.
Most frequently reported reactions
- Off Label Use8 reports
- Fatigue3 reports
- Abortion Spontaneous2 reports
- Anaemia2 reports
- Interstitial Lung Disease2 reports
- Nausea2 reports
- Pain2 reports
- Peripheral Ischaemia2 reports
- Pneumonia2 reports
- Pregnancy2 reports
- Renal Impairment2 reports
- Urinary Tract Infection2 reports
- Abdominal Pain1 reports
- Acute Myocardial Infarction1 reports
- Alopecia1 reports
Counts reflect the most-reported reaction terms (MedDRA preferred terms) associated with reports naming this compound. A single report can list multiple reactions, so reaction counts need not sum to the total number of reports.